GB201600031D0
|
|
Oct-indole hydrochloride pharmaceutical intermediates oct indole synthesis method
|
GB201600028D0
|
|
Pharmaceutical intermediates nafcillin sodium 2-ethoxy-naphthalene synthesis method
|
GB201600023D0
|
|
Pindolol medicine intermediate (a) 4-(2-hydroxy-3-isopropylamino propoxy) indole synthesis method
|
GB201600035D0
|
|
Piroxicam medicine intermediate 3-oxo-1,2-benzisothiazole-1,1-dioxide-acetate synthesis method
|
GB201600033D0
|
|
Metoprolol medicine intermediate methyl styrene ether synthesis method
|
GB201600013D0
|
|
Domperidone medicine intermediate 1-(30chloropropyl)-benzimidazol-2-one synthesis method
|
GB201600011D0
|
|
Isoproterenol medicine intermediate 2,4-hydroxy-a-chloracetophenones synthesis method
|
GB201600019D0
|
|
Olanzapine medicine intermediate 2-(o-nitrophenyl)-3-cyano-5-methyl-thiophene synthesis method
|
GB201600022D0
|
|
Phenylbutazone medicine intermediate n-butyl malonate synthesis method
|
GB201600026D0
|
|
Alprenolol medicine intermediate allyl phenyl ether synthesis method
|
GB201600018D0
|
|
Motillity drugs domperidone synthesis method
|
GB201600032D0
|
|
Barbiturate drugs diethyl malonate intermediate synthesis method
|
GB201600020D0
|
|
Bromhexine pharmaceutical intermediates N-methyl-N-o-nitrobenzyl cyclohexylamine synthesis method
|
GB201600012D0
|
|
Fluvastatin pharmaceutical intermediatez-chloro-1-(4-fluorophenyl) ethanone synthesis method
|
GB201523211D0
|
|
Methoxy kanamycin medicine intermediate y-hthalimido imino -a- hydroxybutyric acid synthesis method
|
GB201523201D0
|
|
Luo liu esters medicine intermediate acetoxy-benzoic phthalazin-3-hydroxphenyl ester synthesis method
|
GB201523203D0
|
|
Cyclic benzene carboxamide medicine intermediate trans -r-N- benzyloxycarbonyl aminomethyl cyclohexane-1-carboxylic acid synthesis method
|
GB201523214D0
|
|
Furan-diamine medicine intermediate N- (2-hydroxyethyl) phthalimide synthesis method
|
GB201523219D0
|
|
Piperidine-carboxylic acid amide pharmaceutical intermediate N- (2,6- dimethylphenoxy) - 4-pyridinecarboxamide synthesis method
|
GB201523221D0
|
|
Balsalazide medicine intermediate Nitrobenzoyl·hydrazone ·P· alanine synthesis method
|